We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 910

First Amendment and off-label promotion prosecute what I do, not what I say

  • Cadwalader Wickersham & Taft LLP
  • -
  • USA
  • -
  • April 21 2014

On December 3, 2012, the United States Court of Appeals for the Second Circuit vacated the conviction of Alfred Caronia ("Caronia"), who had been

Just add water . . . Clinic isn’t a manufacturer

  • Dechert LLP
  • -
  • USA
  • -
  • April 21 2014

Today's case got us thinking about all of the consumer products available that require the purchaser to add water to turn the purchased product into

Court rules Massachusetts’s ban on painkiller preempted

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 17 2014

A federal court in Massachusetts has granted a drugmaker's request to preliminarily enjoin the Commonwealth's ban on a painkiller, finding that the

Zogenix sues Massachusetts to overturn ban of opioid pain drug

  • Frommer Lawrence & Haug LLP
  • -
  • USA
  • -
  • April 14 2014

Zogenix, Inc., the San Diego-based manufacturer of the extended-release hydrocodone drug Zohydro ER, has sued the Governor of Massachusetts in U.S

Hip order on preemption plays a sour note

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 11 2014

The district court's express preemption ruling in Simoneau v. Stryker, Corp., No. 3:13-CV-1200, 2014 U.S. Dist. LEXIS 43137 (D. Conn. Mar. 31, 2014

Will Physician Payment Sunshine Act data usher in a new era of False Claims Act litigation?

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 10 2014

While attention has been focused on Medicare physician payment data released by CMS yesterday, upcoming Sunshine Act data will shine a new spotlight

Common sense contraceptive warnings cases

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 4 2014

Even a casual reader of the blog would know that we like it when drug or device manufacturers defeat dubious claims. It is also no secret that we are

Fourth Circuit upholds dismissal of FCA claims against pharmaceutical services provider

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In United States ex rel. Rostholder v. Omnicare, Inc., --- F.3d ---, No. 12-2431, 2014 WL 661351 (4th Cir. Feb. 21, 2014), the United States Court of

Fifth Circuit affirms preemption of claims against generic manufacturers and rejects innovator liability

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In Lashley v. Pfizer, Inc., 2014 WL 661058 (5th Cir. Feb. 21, 2014), the United States Court of Appeals for the Fifth Circuit held that federal law

Proposition 65 actions dismissed for failure to comply with pre-suit notice requirements

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In Physicians Committee for Responsible Medicine v. McDonald's Corporation, 224 Cal. App 4th 166 (Feb. 27, 2014) (PCRM), the California Court of